patent/CN-101282981-B

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101282981-B

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50e23de05d1725d10d637eeb55d2e73b
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-548 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5383 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-18
filingDate	2006-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate	2012-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f954f484a89b7eeb3a5663b3294194e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e8ca54200725d342f602bf128fd6f54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68da9fba1f9c51155bf8c59708c8216c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65f3037a732f8db8535dab54266f8e62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a459daeff0f5149a2b504a8c3e189e29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0ceff122df66ccb8914180c280a2903 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_951ca6bbd32c5008c75d20097e74f388
publicationDate	2012-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CN-101282981-B
titleOfInvention	Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
abstract	The present invention relates to phosphonated Rifamycins, and methods of making and using such compounds. These compounds are useful as antibiotics for prophylaxis and/or the treatment of bone and joint infections, especially for the prophylaxis and/or treatment of osteomyelitis.
priorityDate	2005-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5880111-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5854227-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6605609-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6333424-B1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466444633 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465363211 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465467761 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466444630 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163705725

Total number of triples: 38.